期刊文献+

重组乙肝病毒核心基因DNA与表面抗原-抗体共免疫应答研究 被引量:1

Study on immune responses induced by co-immunization with recombinant hepatitisB virus core gene DNA and surface antigen-antibody complex
暂未订购
导出
摘要 目的:了解小鼠对乙肝病毒核心抗原(HBcAg)基因免疫及与乙肝表面抗原-抗体复合物(HBsAg-抗HBs)联合免疫的应答。方法:用表达乙肝病毒核心抗原N端144个氨基酸的重组质粒DNA(简称pHBc144)100μg及含1μgHBsAg的重组乙肝表面抗原-鼠抗体组建的复合物(简称sIC)免疫Balb/c小鼠。用ELISA法检测血清抗体IgG和IgG1、IgG2a亚类的效价。用半定量PCR法分别检测鼠脾细胞IFN-γ及IL-4的mRNA。结果:pHBc144及sIC联合免疫鼠的抗HBs IgG、IgG1、IgG2a效价均显著高于sIC组(P<0.05)。同时小鼠还可产生抗HBc及由HBsAg、HBcAg特异诱生的IFN-γ及IL-4。但与sIC共免疫,小鼠对HBcAg诱生的IFN-γ mRNA有所降低。结论:可用HBcAg基因与sIC共免疫,以获得针对乙肝病毒2种结构蛋白的免疫应答。 To study immune responses in mice co-immunized with recombinant hepatitis B virus (HBV) core gene DNA and hepatitis B surface antigen-antibody complex.Methods: One hundred micrograms of DNA from a recombinant expression plasmid, harboring DNA encoding the 144 amino acids of the N-terminus of HBV core gene (abbreviated pHBc144) was used together with one microgram of HB-sAg in the HBsAg-anti-HBs complex (abbreviated sIC) to immunize Balb/c mice. Serum IgG、 IgG1、 IgG2a antibodies were assayed using ELISA, and a semi-quantitative PCR method was used to monitor the mRNA of IFN- and IL-4.Results: Co-immunization with pHBc144 and sIC in mice induced higher titer of anti-HBs IgG、 JgG1 and IgG2a than those immunized only with sIC ( P < 0.05) . All mice produced antibodies versus HBcAg and mouse splenocytes responded by induction of IFN-γ, IL-4 mRNA under stimulation of HBcAg and HBsAg. However, by co-immunization with sIC , IFN-γ mRNA induced by HBcAg was lower than that induced by only pHBc144 immunization. Conclusion: Co-immunization using sIC combined with HBcAg gene could induce immune responses against both structural genes of HBV.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2002年第1期13-16,共4页 Chinese Journal of Immunology
基金 国家863计划重大项目的一部分(编号863-Z18-01-02-01)
关键词 乙肝病毒核心抗原 基因免疫 免疫原性复合物 乙型肝炎 DNA 免疫反应 Hepatitis B virus core antigen Gene immunization Immunogenic complex
  • 相关文献

参考文献2

二级参考文献12

  • 1Li Y,Sci China C,1998年,41卷,47页
  • 2Lin C,J Virol,1994年,68卷,5063页
  • 3Wang B,Proc Nat Acad Sci USA,1993年,90卷,4156页
  • 4Choo Q L,Proc Nat Acad Sci USA,1991年,88卷,2451页
  • 5Wen Y M,Intern Rev Immunol,1999年,8卷,251页
  • 6Roy K,Nature Med,1999年,5卷,387页
  • 7Guidotti L G,Science,1999年,284期,825页
  • 8袁正宏,中华微生物学和免疫学杂志,1999年,19卷,29页
  • 9McCluskie M J,Viral Immunology,1998年,11卷,245页
  • 10Qu D,Viral Immunology,1998年,11卷,65页

共引文献7

同被引文献9

  • 1吴文川,靳大勇,秦新裕,楼文晖,王单松,倪晓凌,吴肇汉.胰腺癌MUC1-VNTR核酸疫苗的构建和体外转染[J].中华实验外科杂志,2005,22(9):1081-1083. 被引量:9
  • 2吴文川,靳大勇,秦新裕,楼文晖,王单松,倪晓凌,吴肇汉.建立胰腺癌黏液蛋白核芯肽-连续重复序列核酸疫苗的实验研究[J].中华普通外科杂志,2006,21(5):357-359. 被引量:7
  • 3Rosenberg L, Lipsett M. Biotherapeutic approaches to pancreatic canc-er. Expert Opin Biol Ther,2003 ,3 :319-337.
  • 4Freelove R,Walling AD. Pancreatic cancer: diagnosis and manage-ment. Am Fam Physician,2006,73 :485492.
  • 5Zalatnai A. Novel therapeutic approaches in the treatment of advancedpancreatic carcinoma. Cancer Treat Rev ,2007 ,33 :289-298.
  • 6Schuman JT,Grinstead JS, Apostolopoulos V,et al. Structural and dy-namic consequences of increasing repeats in a MUC1 peptide tumorantigen. Biopolymers ,2005 ,77 : 107-120.
  • 7Stan AC,Casares S,Brumeanu TD,et al. CpG motifs of DNA vaccinesinduce the expression of chemokines and MHC class II molecules onmyocytes. Eur J Immunol,2001 ,31 :301 -310.
  • 8Chang 5Y,Lee KC,Ko 5Y,et al. Enhanced efficacy of DNA vaccina-tion against Her-2/neu tumor antigen by genetic adjuvants. Int JCancer,2004,111 :86-95.
  • 9吴文川,靳大勇,楼文晖,王单松,秦新裕.免疫增强型胰腺癌MUC1-VNTR—C144DNA疫苗的构建[J].中华实验外科杂志,2009(7):836-838. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部